Insiders Recently Traded Over $100,000 Worth of These Shares

Following is information provided to the SEC today about recent insider trades worth more than $100,000 (e.g., transactions that are (1) exercise of options, (2) purchases of company stock on the open market, or (3) sales of company stock on the open market, and which have a dollar value of at least $100,000):

  • Ameristar Casinos, Inc. (NASDAQ:ASCA): Par Capital Management, Inc. which is a 10% owner, sold 149,272 shares on April 20th at $19.28 per share and 100,000 shares on April 21st, for $19.42 per share, for total proceeds of $4,820,471.  The fund presently holds 3,469,538 shares in the company.  About the company: Ameristar Casinos, Inc. is a multi-jurisdictional gaming company that owns and operates casinos and related hotel, food and beverage, entertainment and other facilities.  The Company’s properties are located in Nevada, Mississippi, and Iowa.  Competitors include: Century Casinos, Inc. (NASDAQ:CNTY), Trans World Corporation (TWOC), Monarch Casino & Resort (NASDAQ:MCRI), Boyd Gaming Corporation (NYSE:BYD), MGM Resorts International (NYSE:MGM), Nevada Gold & Casinos (AMEX:UWN), Pinnacle Entertainment (NYSE:PNK), Wynn Resorts, Limited (NASDAQ:WYNN), and Las Vegas Sands Corp. (NYSE:LVS).
  • Health Spring, Inc. (NYSE:HS): Herbert A. Fitch, who is Chairman and Chief Executive Officer, sold 7,500 shares on April 25th at a market price of $40.15, for total proceeds of $301,125.  He presently holds 2,473,302 shares in the company. About the company: Healthspring, Inc. is a health maintenance organization.  The Company serves Medicare recipients with a comprehensive network of hospitals and physicians. Competitors include: Universal American Corp. (NYSE:UAM), Humana, Inc. (NYSE:HUM), Molina Healthcare, Inc. (NYSE:MOH), WellCare Health Plans (NYSE:WCG), CIGNA Corporation (NYSE:CI), WellPoint, Inc. (NYSE:WLP), HealthNet, Inc. (NYSE:HNT), Aetna, Inc. (NYSE:AET), United Health Group, Inc. (NYSE:UNH), and Coventry Health Care (NYSE:CVH).
  • WABCO Holdings, Inc. (NYSE:WBC): Peter G. Daloia, who is a Director, exercised 54,666 options at a cost of $23.80 per option on April 21st.  He subsequently sold 54,666 shares at a market price of $67.21 per share on April 21st, for net proceeds of $2,373,290.  He presently holds 4,606 shares in the company.  About the company: WABCO Holdings, Inc. manufactures electronic breaking, stability, suspensions and transmission control systems for commercial vehicles.  Competitors include: Meritor, Inc. (MTOR), Tongxin International Ltd. (TXIC), TRW Automotive Holdings (NYSE:TRW), American Axle & Manufacturing (NYSE:AXL), Tower International (NYSE:TOWR), Amerigon Incorporated (NASDAQ:ARGN), Marketing Worldwide Corp. (MWWC), MotivNation Inc (MOVT), Miller Industries, Inc. (NYSE:MLR), and Supreme Industries, Inc. (AMEX:STS).
  • Richardson Electronics, Ltd. (NASDAQ:RELL): Samuel Rubinovitz, who is a Director, exercised 50,000 options at a cost of $9.08 per option on April 20th.  He subsequently sold 50,000 shares at a market price of $13.40 per share on April 20th, for net proceeds of $216,000.  He presently holds 4,606 shares in the company.  About the company: Richardson Electronics, Ltd. distributes electronic components, equipment, and assemblies for industrial, communications, medical, and scientific applications.  The Company’s products include electron tubes, microwave generators, radio frequency and microwave components, power semiconductors, data display monitors, and electronic security products and systems.  Competitors include: Arrow Electronics, Inc. (NYSE:ARW), Avnet, Inc. (NYSE:AVT), Taitron Components, Inc. (NASDAQ:TAIT), AVX Corporation (NYSE:AVX), TESSCO Technologies, Inc. (NASDAQ:TESS), Universal Power Group (AMEX:UPG), Planar Systems, Inc. (NASDAQ:PLNR), General Electric Company (NYSE:GE), ANADIGICS, Inc. (NASDAQ:ANAD), and Anaren, Inc. (NASDAQ:ANEN).
  • Kaiser Aluminum Corporation (NASDAQ:KALU): VEBA For Retireess of Kaiser Aluminum Corporation, which is a 10% owner, sold 5,441 shares at a market price of $48.26 on April 21st.  The fund presently holds 2,973,618 shares in the company.  About the company: Kaiser Aluminum Corporation produces alumina, primary aluminum, and fabricated aluminum products.  The Company also supplies alumina and primary aluminum in domestic and international markets.  Competitors include: Aloca, Inc. (NYSE:AA), Noranda Aluminum Holdings, Inc. (NYSE:NOR), Century Aluminum Company (NASDAQ:CENX), Aluminum Corp. of China (NYSE:ACH), Alumina Limited (NYSE:AWC), and Empire Resources, Inc. (ERSO).
  • First Niagara Financial Group, Inc. (NASDAQ:FNFG): Barbara S. Jeremiah, who is a Director, bought 10,000 shares on April 25th at a market price of $13.79 per share, for a total cost of $310,843.  He presently holds 21,387 shares in the company.  About the company: First Niagara Financial Group, Inc. is a bank holding company.  The Banks provide an array of deposit products and loans, as well as insurance, leasing, investment advisory services, insurance agency services, and trust services.
  • Biogen Idec Inc. (NASDAQ:BIIB): John Cox, who is Executive Vice President, Pharmaceutical Operations and Technology, exercised 4,350 options at a cost of $72.87 per option on April 21st.  He subsequently sold 4,350 shares at a market price of $100 per share on April 21st, for net proceeds of $118,015.  He presently holds 10,353 shares in the company.  About the company: Biogen Idec, Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology.  The Company’s products address diseases such as multiple sclerosis, non-Hodgkin’s lymphoma, rheumatoid arthritis, Crohn’s disease, and psoriasis. Competitors include: Elan Corp. (NYSE:ELN), Amgen, Inc. (NASDAQ:AMGN), Roche Holding Ltd. (RHHBY), Abbott Laboratories (NYSE:ABT), Teva Pharmaceuticals, Inc. (NASDAQ:TEVA), Merck & Co. (NYSE:MRK), Genzyme Corporation (NASDAQ:GENZ), Pfizer, Inc. (NYSE:PFE), GlaxoSmithKline plc (NYSE:GSK), and Bayer AG (BAYRY).
  • Hasbro, Inc. (NYSE:HAS): Brian Goldner, who is President & Chief Executive Officer, bought 10,000 shares on April 21st at a market price of $44.85 per share.  He presently holds 149,974 shares in the company.  Hasbro, Inc. designs, manufactures, and markets toys, games, interactive software, puzzles, and infant products in the United States and internationally.  About the company: The Company’s products include a variety of games, including traditional board, card, hand-held electronic, trading card, role-playing and DVD games, as well as electronic learning aids and puzzles as well as dolls and action figures.  Competitors include: Mattel, Inc. (NASDAQ:MAT), LeapFrog Enterprises (NYSE:LF), JAKKS Pacific, Inc. (NASDAQ:JAKK), RC2 Corporation (NASDAQ:RCRC), and Bally Technologies, Inc. (NYSE:BYI).
  • Wells Fargo & Company (NYSE:WFC): Timothy J. Sloan, who is Senior Executive Vice President and Chief Financial Officer, bought 10,000 shares on April 21st at a market price of $28.54 per share.  He presently holds 69,093 shares in the company.  Judith M Runstad, who is a Director, exercised 6,618 options on April 21st at a cost of $23.78 per option.  She presently holds 19,355 shares in the company.  Cynthia Milligan, who is a Director, exercised 6,618 options at a cost of $23.78 per option on April 21st.  She presently holds 40,374 shares in the company.  About the company: Wells Fargo & Company is a diversified financial services company providing banking, insurance, investments, mortgage, leasing, credit cards, and consumer finance.  The Company operates through physical stores, the Internet and other distribution channels across North America and elsewhere internationally.  Competitors include: Bank of America Corp. (NYSE:BAC), JPMorgan Chase & Co. (NYSE:JPM), Citigroup, Inc. (NYSE:C), US Bancorp (NYSE:USB), PNC Financial Services (NYSE:PNC), SunTrust Banks, Inc. (NYSE:STI), KeyCorp (NYSE:KEY), Goldman Sachs Group, Inc. (NYSE:GS), Regions Financial Corp. (NYSE:RF), and Morgan Stanley (NYSE:MS).
  • United Therapeutics Corporation (NASDAQ:UTHR): Paul A Mahon, who is Executive Vice President and General Counsel, exercised 4,000 options on April 21st at a cost of $28.46 per option.  He subsequently sold 4,000 shares at a market price of $69.86 per share on April 21st, for net proceeds of $165,618.  He presently holds 33,600 shares in the company.  United Therapeutics Corporation develops pharmaceuticals to treat vascular diseases such as pulmonary hypertension and peripheral vascular disease.  The Company’s lead products are stable synthetic forms of prostacyclin and are delivered orally or subcutaneously.  United’s products are currently in Phase III clinical trials.  Competitors include: Pfizer, Inc. (NYSE:PFE), Gilead Sciences, Inc. (NASDAQ:GILD), GlaxoSmithKline plc (NYSE:GSK), Eli Lilly & Co. (NYSE:LLY), Bioheart, Inc. (BHRT), Teva Pharmaceuticals, Inc. (NASDAQ:TEVA), Cardinal Healthcare, Inc. (NYSE:CAH), and BioTime, Inc. (AMEX:BTX).
  • ICU Medical, Inc. (NASDAQ:ICUI): Richard A. Costello, who is Vice President, Sales, sold 11,518 shares at a market price of $45.01 on April 21st, for total proceeds of $480,023.  He presently holds 0 shares in the company.  About the company: ICU Medical, Inc. develops, manufactures, and sells disposable medical connection systems for use in intravenous therapy applications.  The Company’s products are designed to prevent accidental disconnection of IV lines and to protect healthcare workers and their patients from the spread of infectious disease such as Hepatitis B and HIV. Competitors include: Merit Medical Systems, Inc. (NASDAQ:MMSI), Hospira, Inc. (NYSE:HSP), Baxter International, Inc. (NYSE:BAX), Becton, Dickinson and Co. (NYSE:BDX), Insulet Corporation (NASDAQ:PODD), Teleflex Incorporated (NYSE:TFX), CareFusion Corporation (NYSE:CFN), and AngioDynamics, Inc. (NASDAQ:ANGO)
  • Cardinal Health, Inc. (NYSE:CAH): Michael C. Kaufmann, who is Chief Executive Officer, Pharmaceutical Segment, sold 8,560 shares at a market price of $42.95 per share, on April 21st, for total proceeds of $367,652.  He presently holds 62,160 shares in the company.  About the company: Cardinal Health, Inc. provides complementary products and services to healthcare providers and manufacturers.  The Company’s services include pharmaceutical distribution, health-care product manufacturing, distribution and consulting services, drug delivery systems development, pharmaceutical packaging, automated dispensing systems manufacturing, and retail pharmacy franchising. Competitors include: AmerisourceBergen Corp. (NYSE:ABC), McKesson Corporation (NYSE:MCK), Integra LifeSciences (NASDAQ:IART), Thermo Fisher Scientific (NYSE:TMO), Teleflex Inc. (NYSE:TFX), Covidien plc (NYSE:COV), General Electric Company (NYSE:GE), CVS Caremark Corporation (NYSE:CVS), Walgreen Company (NYSE:WAG), and Owens & Minor, Inc. (NYSE:OMI).

Don’t Miss: Wall St. Cheat Sheet’s newest Feature Trades of the Month!

More from The Cheat Sheet